Bharat Immunological & Biological Corporation Ratios

Bharat Immunological & Biological Corporation Ltd Ratios

The Bharat Immunological & Biological Corporation Ltd Ratios page provides a complete fundamental analysis of Bharat Immunological & Biological Corporation Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Bharat Immunological & Biological Corporation Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.

Bharat Immunological & Biological Corporation Ltd (NSE: , BSE: 524663) is currently trading at ₹16.72, with a market capitalization of ₹721.97M. As a major player in the Health technology sector and Pharmaceuticals: major industry, Bharat Immunological & Biological Corporation Ltd remains a key stock for fundamental analysis using Bharat Immunological & Biological Corporation Ltd Ratios.

Bharat Immunological & Biological Corporation Ltd Ratios: Valuation Overview

Price to Earnings Ratio (P/E)

The Bharat Immunological & Biological Corporation Ltd P/E ratio currently stands at 0, making it one of the most tracked metrics in Bharat Immunological & Biological Corporation Ltd Ratios.

Historically, the Bharat Immunological & Biological Corporation Ltd P/E ratio has shown strong fluctuations:

The decline in Bharat Immunological & Biological Corporation Ltd P/E ratio suggests improving earnings relative to stock price.

Price to Book Ratio (P/B)

The Bharat Immunological & Biological Corporation Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 0.

Historical P/B trend:

Bharat Immunological & Biological Corporation Ltd shows reasonable valuation compared to its asset base.

Price to Sales Ratio (P/S)

The Bharat Immunological & Biological Corporation Ltd P/S ratio currently stands at 0, an important part of Bharat Immunological & Biological Corporation Ltd Ratios for revenue valuation.

Historical P/S ratio:

A stable or declining Bharat Immunological & Biological Corporation Ltd P/S ratio indicates cautious market sentiment.

Bharat Immunological & Biological Corporation Ltd Price to Cash Flow Ratio (P/CF)

The Bharat Immunological & Biological Corporation Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.

Historical Bharat Immunological & Biological Corporation Ltd Price to Cash Flow Ratio:

The declining Bharat Immunological & Biological Corporation Ltd Price to Cash Flow Ratio suggests improving cash flow strength.

Bharat Immunological & Biological Corporation Ltd Enterprise Value Ratios

Enterprise Value (EV)

The Bharat Immunological & Biological Corporation Ltd EV currently stands at ₹0, representing the total company valuation including debt.

Historical EV trend:

Bharat Immunological & Biological Corporation Ltd enterprise value consolidation suggests stable valuation.

EV/EBITDA Ratio

The Bharat Immunological & Biological Corporation Ltd EV/EBITDA ratio is currently 0, a key metric in Bharat Immunological & Biological Corporation Ltd Ratios to assess valuation relative to earnings.

Historical EV/EBITDA:

Stable Bharat Immunological & Biological Corporation Ltd EV/EBITDA indicates balanced valuation.

Bharat Immunological & Biological Corporation Ltd Financial Strength Ratios

Debt to Equity Ratio (D/E)

The Bharat Immunological & Biological Corporation Ltd D/E ratio is currently 0, reflecting leverage and financial stability.

Historical D/E:

Bharat Immunological & Biological Corporation Ltd maintains a strong balance sheet with low debt levels.

Return on Equity (ROE %)

The Bharat Immunological & Biological Corporation Ltd ROE currently stands at 0%, showing profitability and capital efficiency.

Historical ROE:

Declining ROE indicates pressure on profitability.

Bharat Immunological & Biological Corporation Ltd Ratios Analysis Summary

The Bharat Immunological & Biological Corporation Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Bharat Immunological & Biological Corporation Ltd stock is undervalued, fairly valued, or overvalued.

Tracking Bharat Immunological & Biological Corporation Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.